InvestorsHub Logo
icon url

Investor2014

12/02/18 9:38 AM

#173471 RE: nidan7500 #173470

This suggests to me why the FDA abandoned decades of massively expensive AD trials which ultimately could not be justified as clinically useful.



I don't FDA abandoned any trials. More likely the pharma company sponsors did when results did not meet expectations and quite likely not the evolving view of the FDA.
icon url

Jonjones325

12/02/18 10:32 AM

#173478 RE: nidan7500 #173470

When will Biogen get the memo?